Table 3.
Treatment Group | 0.5 g/kg |
1.0 g/kg |
1.5 g/kg |
|||
---|---|---|---|---|---|---|
Minutes Post-Injection | 15 | 75 | 15 | 75 | 15 | 75 |
HAP1 Male | 48.0±6.2 | 6.1±1.2 | 102.2±9.3 | 32.7±10.3 | 147.6±18.5 | 84.6±11.4 |
LAP1 Male | 40.6±5.8 | 5.8±1.1 | 96.3±9.6 | 31.9±5.1 | 160.5±13.6 | 102.5±7.2 |
HAP1 Female | 39.0±5.6 | 5.3±1.0 | 90.6±12.4 | 18.3±3.3 | 165.0±13.4 | 93.4±4.9 |
LAP1 Female | 44.7±5.0 | 5.9±2.2 | 94.8±15.3 | 22.0±5.6 | 156.1±13.1 | 103.3±5.9 |
HAP2 Male | 41.7±4.0 | 3.4±0.8 | 80.3±11.8 | 21.8±4.5 | 114.1±14.6 | 89.8±10.8 |
LAP2 Male | 36.8±5.2 | 6.0±0.9 | 84.0±16.3 | 27.9±7.4 | 134.1±19.9 | 90.6±20.0 |
HAP2 Female | 37.2±3.9 | 4.0±0.9 | 78.9±7.7 | 23.5±5.4 | 115.8±15.2 | 98.2±14.5 |
LAP2 Female | 34.2±2.4 | 4.5±0.8 | 83.9±8.4 | 26.0±4.3 | 108.7±8.3 | 91.1±9.6 |
Mean (± SEM) BAC (mg of alcohol/dl of plasma) at 15 and 75 min in HAP and LAP mouse lines treated with IP injections of 0.5, 1.0, and 1.5 g/kg alcohol